Cancer Drugs

Tempest Therapeutics’ inventory jumps 1,900% as liver-cancer remedy exhibits promise

Bristol Myers Squibb to purchase Mirati Therapeutics in deal value as much as $5.8 billion

Amgen to proceed to hunt full approval of Lumakras most cancers drug after FDA panel votes in opposition to it

Merck and Eisai say two lung-cancer trials failed to satisfy their major objectives

3M, Hawaiian Electric shares surge, NovoCure shares plunge and different shares on the transfer

New blood take a look at guarantees to detect cancerous tumors earlier than they’re shaped

Novartis will get constructive consequence from breast-cancer drug trial

FDA committee backs Roche’s lymphoma remedy

AstraZeneca says most cancers drug Enhertu confirmed optimistic outcomes

Pfizer eyes takeover of biotech Seagen, at worth of greater than $30 billion